Structural imaging differences and longitudinal changes in primary lateral sclerosis and amyotrophic lateral sclerosis
- PMID: 24179768
- PMCID: PMC3778247
- DOI: 10.1016/j.nicl.2012.12.003
Structural imaging differences and longitudinal changes in primary lateral sclerosis and amyotrophic lateral sclerosis
Abstract
Magnetic resonance imaging measures have been proposed as objective markers to study upper motor neuron loss in motor neuron disorders. Cross-sectional studies have identified imaging differences between groups of healthy controls and patients with amyotrophic lateral sclerosis (ALS) or primary lateral sclerosis (PLS) that correlate with disease severity, but it is not known whether imaging measures change as disease progresses. Additionally, whether imaging measures change in a similar fashion with disease progression in PLS and ALS is unclear. To address these questions, clinical and imaging evaluations were first carried out in a prospective cross-sectional study of 23 ALS and 22 PLS patients with similar motor impairment and 19 age-matched healthy controls. Clinical evaluations consisted of a neurological examination, the ALS Functional rating scale-revised, and measures of finger tapping, gait, and timed speech. Age and ALSFRS score were not different, but PLS patients had longer duration of symptoms. Imaging measures examined were cortical thickness, regional brain volumes, and diffusion tensor imaging of the corticospinal tract and callosum. Imaging measures that differed from controls in a cross-sectional vertex-wise analysis were used as regions of interest for longitudinal analysis, which was carried out in 9 of the ALS patients (interval 1.26 ± 0.72 years) and 12 PLS patients (interval 2.08 ± 0.93 years). In the cross-sectional study both groups had areas of cortical thinning, which was more extensive in motor regions in PLS patients. At follow-up, clinical measures declined more in ALS than PLS patients. Cortical thinning and grey matter volume loss of the precentral gyri progressed over the follow-up interval. Fractional anisotropy of the corticospinal tracts remained stable, but the cross-sectional area declined in ALS patients. Changes in clinical measures correlated with changes in precentral cortical thickness and grey matter volume. The rate of cortical thinning was greater in ALS patients with shorter disease durations, suggesting that thickness decreases in a non-linear fashion. Thus, cortical thickness changes are a potential imaging marker for disease progression in individual patients, but the magnitude of change likely depends on disease duration and progression rate. Differences between PLS and ALS patients in the magnitude of thinning in cross-sectional studies are likely to reflect longer disease duration. We conclude that there is an evolution of structural imaging changes with disease progression in motor neuron disorders. Some changes, such as diffusion properties of the corticospinal tract, occur early while cortical thinning and volume loss occur later.
Keywords: ALS, amyotrophic lateral sclerosis; ALSFRS-R, ALS functional rating scale, revised; CC, corpus callosum; CST, corticospinal tract; Cortical thickness; DTI, diffusion tensor imaging; Diffusion tensor imaging; FA, fractional anisotropy; FreeSurfer; Longitudinal studies; MD, mean diffusivity; MRI, magnetic resonance imaging; Motor neuron disease; PLS, primary lateral sclerosis; UMN, upper motor neuron.
Figures
Similar articles
-
Differential involvement of corticospinal tract (CST) fibers in UMN-predominant ALS patients with or without CST hyperintensity: A diffusion tensor tractography study.Neuroimage Clin. 2017 Feb 22;14:574-579. doi: 10.1016/j.nicl.2017.02.017. eCollection 2017. Neuroimage Clin. 2017. PMID: 28337412 Free PMC article.
-
Cross-sectional and longitudinal assessment of the upper cervical spinal cord in motor neuron disease.Neuroimage Clin. 2019;24:101984. doi: 10.1016/j.nicl.2019.101984. Epub 2019 Aug 16. Neuroimage Clin. 2019. PMID: 31499409 Free PMC article.
-
Interhemispheric connectivity in amyotrophic lateral sclerosis: A near-infrared spectroscopy and diffusion tensor imaging study.Neuroimage Clin. 2016 Sep 29;12:666-672. doi: 10.1016/j.nicl.2016.09.020. eCollection 2016. Neuroimage Clin. 2016. PMID: 27761397 Free PMC article.
-
[Objective markers for upper motor neuron involvement in amyotrophic lateral sclerosis].Brain Nerve. 2007 Oct;59(10):1053-64. Brain Nerve. 2007. PMID: 17969345 Review. Japanese.
-
Neuroimaging in primary lateral sclerosis.Amyotroph Lateral Scler Frontotemporal Degener. 2020 Nov;21(sup1):18-27. doi: 10.1080/21678421.2020.1837176. Amyotroph Lateral Scler Frontotemporal Degener. 2020. PMID: 33602015 Review.
Cited by
-
Advances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis.BMJ. 2023 Oct 27;383:e075037. doi: 10.1136/bmj-2023-075037. BMJ. 2023. PMID: 37890889 Free PMC article. Review.
-
Simultaneous PET/MRI: The future gold standard for characterizing motor neuron disease-A clinico-radiological and neuroscientific perspective.Front Neurol. 2022 Aug 17;13:890425. doi: 10.3389/fneur.2022.890425. eCollection 2022. Front Neurol. 2022. PMID: 36061999 Free PMC article. Review.
-
Frontotemporal Pathology in Motor Neuron Disease Phenotypes: Insights From Neuroimaging.Front Neurol. 2021 Aug 16;12:723450. doi: 10.3389/fneur.2021.723450. eCollection 2021. Front Neurol. 2021. PMID: 34484106 Free PMC article. Review.
-
Upper Motor Neuron Disorders: Primary Lateral Sclerosis, Upper Motor Neuron Dominant Amyotrophic Lateral Sclerosis, and Hereditary Spastic Paraplegia.Brain Sci. 2021 May 11;11(5):611. doi: 10.3390/brainsci11050611. Brain Sci. 2021. PMID: 34064596 Free PMC article. Review.
-
Clinical care and therapeutic trials in PLS.Amyotroph Lateral Scler Frontotemporal Degener. 2020 Nov;21(sup1):67-73. doi: 10.1080/21678421.2020.1837180. Amyotroph Lateral Scler Frontotemporal Degener. 2020. PMID: 33602017 Free PMC article.
References
-
- Agosta F., Gorno-Tempini M.L., Pagani E., Sala S., Caputo D., Perini M., Bartolomei I., Fruguglietti M.E., Filippi M. Longitudinal assessment of grey matter contraction in amyotrophic lateral sclerosis: a tensor based morphometry study. Amyotrophic Lateral Sclerosis. 2009;10:168–174. - PubMed
-
- Agosta F., Pagani E., Petrolini M., Caputo D., Perini M., Prelle A., Salvi F., Filippi M. Assessment of white matter tract damage in patients with amyotrophic lateral sclerosis: a diffusion tensor MR imaging tractography study. AJNR. American Journal of Neuroradiology. 2010;31:1457–1461. - PubMed
-
- Agosta F., Pagani E., Petrolini M., Sormani M.P., Caputo D., Perini M., Prelle A., Salvi F., Filippi M. MRI predictors of long-term evolution in amyotrophic lateral sclerosis. European Journal of Neuroscience. 2010;32:1490–1496. - PubMed
-
- Agosta F., Valsasina P., Absinta M., Riva N., Sala S., Prelle A., Copetti M., Comola M., Comi G., Filippi M. Sensorimotor functional connectivity changes in amyotrophic lateral sclerosis. Cerebral Cortex. 2011;21:2291–2298. - PubMed
-
- Agosta F., Canu E., Valsasina P., Riva N., Prelle A., Comi G., Filippi M. Divergent brain network connectivity in amyotrophic lateral sclerosis. Neurobiology of Aging. 2012 (May 17 [Epub ahead of print]) - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
